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The data presented in this article relate to the research article
entitled “Risk of incident myocardial infarction by gender: Inter-
actions with serum lipids, blood pressure and smoking. The
Tromsø Study 1979–2012” (Albrektsen et al., 2017) [1]. Data
quantify the gender differences in the risk of myocardial infarction
(MI) in terms of incidence rate ratios (IRR), in subgroups deﬁned
by serum lipids, blood pressure and smoking among persons aged
35–54 years, 55–74 years and 75–94 years, respectively. Data also
describe the age- and gender-speciﬁc linear associations with the
coronary heart disease (CHD) risk factors. IRRs for combined
categories of age, gender and a CHD risk factor, with each category
compared to the same reference group, are also shown. IRRs
were calculated as estimates of relative risk in Poisson regressionvier Inc. This is an open access article under the CC BY license
/j.atherosclerosis.2017.04.009
Research, Faculty of Medicine and Health Science, NTNU - Norwegian
gate 14, Pb. 8905, 7491 Trondheim, Norway.
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G. Albrektsen et al. / Data in Brief 13 (2017) 779–784780analyses of person-years at risk. Among 33,859 individuals at risk,
a total of 622, 1308 and 816 were diagnosed with MI at ages 35–54,
55–74 and 75–94 years, respectively.
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Medicine
ore speciﬁc
subject areaCoronary heart disease epidemiologyype of data Tables and Figures
ow data was
acquiredPoisson regression analyses of person-years at risk, with calculations based on
information obtained from a large population-based prospective studyata format Analyzed
xperimental
factors
xperimental
features
ata source
locationTromsø, Norwayata accessibility The data are available with this articleValue of the data
 Data can be used for identifying subgroups where the gender contrast in risk of incident MI is
particularly high or low.
 Data can be used for evaluation of gender heterogeneity in the association with established CHD
risk factors.
 Data can be used for comparing risk of incident MI between any subgroups deﬁned by age, gender
and a CHD risk factor.
 Data can be utilized for exploring issues that can improve knowledge on biological mechanisms
underlying the gender contrast in the risk of CHD.
 At the community level, data can be utilized for development of gender-speciﬁc CHD risk
preventive guidelines.1. Data
Data displayed in Table 1 are age- and gender-speciﬁc incidence rate ratios (IRR) of myocardial
infarction (MI) with 95% conﬁdence intervals (CI) for the linear associations with total cholesterol,
high-density lipoprotein cholesterol (HDL-C), and HDL-C in percent of total cholesterol. Data shown in
Table 2 are the age-speciﬁc IRR for gender (men vs. women) within categories deﬁned by the lipid
components. Tables 3 and 4 show corresponding numbers for the interaction between gender and
systolic and diastolic blood pressure, and Table 5 shows IRR for the interaction between gender and
daily smoking. The number of MI-diagnoses within each subgroup deﬁned by age, gender and a CHD
risk factor, is also shown. Fig. 1A-F show IRR values from analyses of combined categories of age
(35–54, 55–74 and 75–94 years), gender and each CHD risk factor, with each subgroup compared to
the same reference group. The data are original and have not been published elsewhere.
Table 2
Age-speciﬁc incidence rate ratio of myocardial infarction for gender within serum lipid categories. The Tromsø Study 1979–
2012.
35–54 years 55–74 years 75–94 years
No. of MI IRR (95% CI)a No. of MI IRR (95% CI)a No. of MI IRR (95% CI)a
M W Men vs. women M W Men vs. women M W Men vs. women
TC (mmol/L)b,c
o5.0 34 7 4.73 (2.09–10.7) 60 17 1.87 (1.09–3.21) 57 31 1.13 (0.72–1.76)
5.0–6.4 165 27 4.21 (2.79–6.36) 335 107 1.85 (1.48–2.31) 172 116 1.55 (1.21–1.98)
6.5–7.9 223 35 3.22 (2.24–4.62) 418 152 2.27 (1.87–2.75) 124 184 1.68 (1.31–2.14)
Z8.0 120 11 4.61 (2.54–8.39) 146 73 2.28 (1.71–3.03) 38 94 2.23 (1.52–3.29)
p, interactiond 0.62 0.49 0.15
HDL-C (mmol/L)b,c
o1.00 107 3 –e 150 26 1.96 (1.29–2.98) 48 28 1.44 (0.90–2.30)
1.0–1.29 243 21 4.37 (2.91–6.57) 351 81 1.98 (1.55–2.53) 132 104 1.35 (1.03–1.77)
1.3–1.59 126 26 3.58 (2.34–5.46) 282 107 2.21 (1.77–2.77) 116 115 1.72 (1.31–2.25)
1.6–1.89 48 18 3.92 (2.28–6.75) 114 76 2.09 (1.56–2.80) 52 88 1.60 (1.12–2.28)
Z1.90 18 12 3.33 (1.60–6.92) 62 59 2.30 (1.61–3.30) 43 90 2.16 (1.48–3.14)
p, interactiond 0.89 0.94 0.33
HDL-C/TC (%)
o15 161 9 4.15 (2.12–8.13) 195 38 2.48 (1.75–3.52) 48 48 1.57 (1.04–2.36)
15–19.9 211 26 2.91 (1.94–4.38) 365 108 1.89 (1.52–2.35) 101 122 1.25 (0.95–1.65)
20–24.9 94 18 3.49 (2.10–5.78) 217 94 1.92 (1.50–2.45) 121 124 1.89 (1.45–2.45)
25–29.9 45 13 4.03 (2.17–7.47) 114 55 2.13 (1.54–2.94) 65 65 1.96 (1.38–2.79)
Z30 31 14 4.84 (2.57–9.12) 68 54 1.86 (1.30–2.66) 56 66 1.74 (1.21–2.51)
p, interactiond 0.70 0.69 0.17
MI, myocardial infarction; IRR, incidence rate ratio; CI, conﬁdence interval; M, men; W, women; TC, total cholesterol; HDL-C,
high-density lipoprotein cholesterol.
a Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), diastolic blood pressure (linear trend) and
daily smoking.
b Additional adjustment for HDL-C or total cholesterol.
c To convert mmol/L to mg/dL, divide by 0.0259 (or multiply with 38.61004).
d Likelihood ratio test for categorical interaction (gender*lipid component) within age groups.
e Two ﬁrst categories collapsed.
Table 1
Age- and gender-speciﬁc incidence rate ratio of myocardial infarction for linear association with serum lipids. The Tromsø
Study 1979–2012.
35–54 years 55–74 years 75–94 years
IRR (95% CI)a IRR (95% CI)a IRR (95% CI)a p, interactionb
TC (per 1.50 mmol/L)c,d
– Men 2.02 (1.82–2.23) 1.54 (1.43–1.67) 1.21 (1.07–1.38) o0.001
– Women 2.10 (1.64–2.70) 1.38 (1.21–1.56) 1.06 (0.95–1.20) o0.001
p, interactione 0.75 0.12 0.13
HDL-C (per 0.30 mmol/L)c,d
– Men 0.72 (0.66–0.79) 0.76 (0.72–0.81) 0.91 (0.84–0.99) o0.001
– Women 0.76 (0.63–0.92) 0.73 (0.67–0.80) 0.82 (0.76–0.88) 0.27
p, interactione 0.62 0.44 0.062
HDL-C/TC (per 5%)
– Men 0.60 (0.55–0.64) 0.68 (0.64–0.72) 0.89 (0.82–0.96) o0.001
– Women 0.57 (0.48–0.68) 0.71 (0.65–0.78) 0.81 (0.75–0.88) o0.001
p, interactione 0.66 0.42 0.12
IRR, incidence rate ratio; CI, conﬁdence interval; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol.
a IRR for linear trend through ordered lipid categories (see Table 2), adjusted for age (1-year interval, categorical), birth-
cohort (5-year categories), diastolic blood pressure (linear trend) and daily smoking.
b Likelihood ratio test for linear interaction (age*lipid component) for men and women.
c Additional adjustment for HDL-C or total cholesterol.
d To convert mmol/L to mg/dL, divide by 0.0259 (or multiply with 38.61004).
e Likelihood ratio test for linear interaction (gender*lipid component) within age groups.
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Table 3
Age- and gender-speciﬁc incidence rate ratio of myocardial infarction for linear association with blood pressure. The Tromsø
study 1979–2012.
35–54 years 55–74 years 75–94 years
IRR (95% CI)a IRR (95% CI)a IRR (95% CI)a p, interactionb
SBP (per 20 mmHg)
– Men 1.53 (1.38–1.70) 1.21 (1.14–1.29) 1.16 (1.06–1.27) 0.002
– Women 1.70 (1.36–2.13) 1.41 (1.29–1.55) 1.29 (1.18–1.41) 0.39
p, interactionc 0.40 0.007 0.10
DBP (per 10 mmHg)
– Men 1.45 (1.33–1.58) 1.20 (1.13–1.28) 1.07 (0.97–1.18) o0.001
– Women 1.74 (1.42–2.13) 1.34 (1.22–1.48) 1.24 (1.13–1.37) 0.039
p, interactionc 0.095 0.045 0.038
IRR, incidence rate ratio; CI, conﬁdence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure.
a IRR for linear trend through ordered blood pressure categories (see Table 4), adjusted for age (1-year interval, categorical),
birth-cohort (5-year categories), HDL-C in percent of total cholesterol (linear trend), and daily smoking.
b Likelihood ratio test for linear interaction (age*BP) for men and women.
c Likelihood ratio test for linear interaction (gender*BP) within age groups.
Table 4
Age-speciﬁc incidence rate ratio of myocardial infarction for gender within blood pressure categories. The Tromsø Study 1979–
2012.
35–54 years 55–74 years 75–94 years
No. of MI IRR (95% CI)a No. of MI IRR (95% CI)a No. of MI IRR (95% CI)a
M W Men vs. women M W Men vs. women M W Men vs. women
SBP (mmHg)
o120 54 18 4.67 (2.73–8.01) 75 30 3.20 (2.09–4.89) 16 8 2.52 (1.08–5.90)
120–139 250 39 3.02 (2.15–4.26) 345 88 2.53 (2.00–3.20) 77 53 1.91 (1.34–2.72)
140–159 188 14 4.45 (2.58–7.68) 336 119 1.95 (1.58–2.42) 132 114 1.75 (1.35–2.27)
160–179 41 5 2.31 (1.13–4.71) 153 77 1.73 (1.31–2.28) 108 120 1.91 (1.46–2.51)
Z180 9 4 –b 50 35 1.70 (1.10–2.62) 58 130 1.30 (0.94–1.79)
p, interactionc 0.28 0.047 0.28
DBP (mmHg)
o70 41 10 5.33 (2.66–10.7) 50 37 2.75 (1.80–4.21) 48 44 2.34 (1.55–3.54)
70–79 130 19 4.69 (2.89–7.62) 212 84 2.30 (1.78–2.96) 94 93 1.63 (1.21–2.18)
80–89 196 28 3.21 (2.15–4.78) 342 121 1.95 (1.58–2.40) 150 157 1.69 (1.33–2.14)
90–99 109 17 2.58 (1.54–4.31) 237 78 1.62 (1.25–2.10) 90 126 1.36 (1.04–1.80)
Z100 66 6 3.03 (1.31–7.01) 118 29 1.91 (1.27–2.87) 9 5 –b
p, interactionc 0.34 0.20 0.18
MI, myocardial infarction; IRR, incidence rate ratio; CI, conﬁdence interval; M, men; W, women; SBP, systolic blood pressure;
DBP, diastolic blood pressure.
a Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol
(linear trend), and daily smoking.
b Two last categories collapsed.
c Likelihood ratio test for categorical interaction (gender*BP) within age groups.
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Table 5
Age-speciﬁc incidence rate ratio of myocardial infarction for gender in smokers and non-smokers, and age- and gender-speciﬁc
associations with smoking. The Tromsø Study 1979–2012.
35–54 years 55–74 years 75–94 years
No. of MI IRR (95% CI)a No. of MI IRR (95% CI)a No. of MI IRR (95% CI)a
M W Men vs. women M W Men vs. women M W Men vs. women
Smoking, daily
No 60 8 4.57 (2.17–9.60) 143 88 2.51 (1.92–3.28) 62 237 1.95 (1.47–2.58)
Former (F) 108 8 5.27 (2.56–10.9) 302 65 2.21 (1.67–2.90) 240 100 1.75 (1.38–2.21)
Yes 374 64 3.25 (2.48–4.27) 514 196 1.76 (1.48–2.08) 89 88 1.23 (0.91–1.65)
IRR, F vs. No
– Men 1.80 (1.31–2.48) 1.04 (0.85–1.27) 1.12 (0.81–1.55)
– Women 1.56 (0.59–4.16) 1.18 (0.86–1.63) 1.20 (0.95–1.52)
IRR, Yes vs. No
– Men 3.68 (2.79–4.85) 1.91 (1.59–2.31) 1.08 (0.82–1.43)
– Women 5.17 (2.47–10.8) 2.74 (2.13–3.52) 1.78 (1.39–2.28)
p, interactionb 0.34 0.057 0.067
MI, myocardial infarction; IRR, incidence rate ratio; CI, conﬁdence interval; M, men; W, women.
a Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol
(linear trend) and diastolic blood pressure (linear trend).
b Likelihood ratio test for categorical interaction (gender*smoking) within age groups.
Fig. 1. Relative risk in combined categories of interacting factors. Adjusted incidence rate ratio (IRR, on logarithmic scale) of
myocardial infarction in combined categories of age (— .— 35-54 yr, _____ 55-74 yr, - - - - 75-94 yr), gender ( men, women)
and (A) total cholesterol, (B) HDL-C, (C) HDL-C in percent of total cholesterol, (D) systolic BP, (E) diastolic BP, (F) daily smoking.
The horizontal reference line (IRR = 1.00) in each ﬁgure goes through the common reference group.
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G. Albrektsen et al. / Data in Brief 13 (2017) 779–7847842. Experimental design, materials and methods
2.1. Population at risk
Data displayed are calculated on the basis of information from the Tromsø Study in Norway [1,2].
Individual risk factor levels were obtained through questionnaires, blood samples and physical
examinations in ﬁve repeated surveys in the calendar period 1979–2008. CHD risk factor levels in
men and women at start of follow-up are given elsewhere [3]. Dates of MI-diagnoses, emigration and
deaths in the period 1979–2012 were obtained from local and national registers. Among 33,859
individuals at risk (51% women), a total of 622 (80 women), 1308 (349 women) and 816 (425 women)
had an MI at ages 35–54, 55–74 and 75–94 years, respectively.
2.2. Statistical analysis
The data are obtained from Poisson regression analyses of person-years at risk, with IRR of inci-
dent MI calculated as estimates of relative risk [4,5]. Information from all repeated surveys was
utilized [1]. The data shown in Tables 1–5 are calculated on the basis of two-way interaction models
(between gender and a CHD risk factor) in separate analyses of persons aged 35–54, 55–74 and 75–94
years (corresponding to a three-way interaction model). Within each broad age group, IRRs were
adjusted for age in 1-year categories. The data displayed in Tables 1–5 quantify subgroup-speciﬁc
associations with each single risk factor, but provide no information on whether a high-risk group
among young people encloses, or possibly crosses the risk level of any older subgroup.
Data displayed in Fig. 1A–F are obtained from analyses of a single variable representing combined
categories of age (35–54, 55–74 and 75–94 years), gender and a CHD risk factor (a unique value
assigned to each possible value combination). A subgroup in middle-aged women with sufﬁcient
number of MI cases, as close as possible to normal-range or unexposed for the CHD risk factor
considered, was used as common reference group when calculating the IRRs, and the risk estimates
for all subgroups can be compared directly. The internal order of the IRRs will also reﬂect the rank of
absolute risks. To ensure that persons in one particular broad age group were compared with persons
exactly 20 years older or younger, additional indicator variables for age were included in the model
(1-year categories, original age variable recoded 1–20 within each broad age group). The data pre-
sented in Fig. 1A–F provide information on whether a high-risk group in young people encloses the
risk level of any older subgroup, but do not quantify the association with each single risk factor.
The regression models used for generating the data are an extension of the two-way interaction
models applied in the original research paper [1], to three-way-interaction models used for evalua-
tion of homogeneity across age-groups.
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